Long noncoding RNAs in cancer-immunity cycle

J Cell Physiol. 2018 Sep;233(9):6518-6523. doi: 10.1002/jcp.26568. Epub 2018 Mar 25.

Abstract

The imbalance of immune status in cancer microenvironment plays an important role in the development and progression of cancer. Immunotherapy based on this has become an important field of cancer research in recent years. Many studies on long noncoding RNA (lncRNA) in cancer have focus on its regulation in cancer development and metastasis. Recent studies have suggested that lncRNAs play crucial roles in different phases of cancer immunity, including antigen releasing, antigen presentation, immune activation, immune cells migration, infiltrating into cancer tissues, and killing cancer cells. The functional studies of lncRNAs in cancer immuntity revealed the complicated molecular mechanisms in cancer immunity from a new point of view, which may provide novel potential targets for cancer immunotherapies. Based on the classical cancer-immunity cycle theory, we review the recent studies on the functions and mechanisms of immune-related lncRNAs in different stages of cancer immunity, to summarize the relationship between lncRNAs, and cancer immunity and to provide a framework for further research.

Keywords: cancer; cancer-immunity cycle; immunity; lncRNA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Immunity / genetics*
  • Immunity / immunology*
  • Immunotherapy / methods
  • Neoplasms / genetics*
  • Neoplasms / immunology*
  • Neoplasms / therapy
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / immunology*
  • Tumor Microenvironment / genetics
  • Tumor Microenvironment / immunology

Substances

  • RNA, Long Noncoding